About Dallas Formulations Private Limited
Data last updated:
Dallas Formulations Private Limited is a private limited company based in Ujjain, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 November 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24233MP2000PTC014476. Its GSTIN is 02AACCD5000G1ZJ (Himachal Pradesh).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹39.09 Lakh. It was formerly known as Chirayu Ayurveda Private Limited. It is led by directors Mukesh Kumar (Whole-Time Director) and Rajesh Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 220 Block – C 2nd Floor Madhav Club Road Dawa Bazar, Ujjain, Madhya Pradesh, India – 456010.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.53 Cr, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹17.31 Lakh (net margin 1.6%) and EBITDA of ₹85.56 Lakh (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 2% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Dallas Formulations. As per MCA filings, the company has open charges of ₹2.66 Cr and satisfied charges of ₹5.24 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dallaspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address220 Block – C 2nd Floor Madhav Club Road Dawa Bazar, Ujjain, Madhya Pradesh, India – 456010
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Dallas Formulations Private Limited
Dallas Formulations operates one associated brand: Dallas Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical tablets, capsules, and injectables for health markets. | dallaspharma.com |
Competitors & Alternatives of Dallas Formulations Private Limited
Brands and companies operating in the same space as Dallas Formulations Private Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Jubilant Life Sciences | Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India | 1978 |
 Akums | CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India | 2004 |
 Nectar Lifesciences | Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India | 1995 |
 Windlas | Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India | 2001 |
 Unither | Contract development and manufacturing organization for proprietary and generic drugs | Paris, France | 1993 |
 Recipharm | Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden | 1995 |
 CoreRx | CDMO with a focus on early phase drug product development | Clearwater, United States | 2006 |
 MedPharm | Topical and inhaled drug delivery formulations are developed and manufactured. | Guildford, United Kingdom | 1998 |
Business Activity of Dallas Formulations Private Limited
The main business activity of Dallas Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Dallas Formulations Private Limited
Dallas Formulations Private Limited is audited by V.K. Ladha & Associates for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V.K. Ladha & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dallas Formulations Private Limited
Dallas Formulations has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Gupta Also directs: Rudraksha Entertainment LLP, Dallas Drugs Private Limited, Dauket Pharma Private Limited and 3 more | Director | 16 Jan 2006 | 20 Years 8 Months | Current |
| Mukesh Kumar | Whole-Time Director | 21 Jul 2022 | 4 Years 2 Months | Current |
Financials of Dallas Formulations Private Limited FY 2024 filings available
Dallas Formulations Private Limited reported revenue of ₹10.53 Cr (up 47% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dallas Formulations Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 47% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dallas Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹85.56 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹17.31 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dallas Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dallas Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Dallas Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dallas Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2006 | State Bank of India | ₹2.66 Cr | Open |
| 28 Nov 2013 | Ing Vysya Bank Limited | ₹1.75 Cr | Satisfied |
| 17 Aug 2011 | Dir. of Industries with Parri Passu Sbi Baddi | ₹1.29 Cr | Satisfied |
| 29 Apr 2006 | State Bank of India | ₹2.2 Cr | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Dallas Formulations Private Limited
Dallas Formulations Private Limited has a workforce of 22 employees as of Mar 24, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Dallas Formulations Private Limited
Dallas Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AACCD5000G1ZJ | Himachal Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Dallas Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dallas Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dallas Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dallas Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Dallas Formulations Private Limited
Frequently Asked Questions about Dallas Formulations Private Limited
Dallas Formulations is an active private limited company based in Ujjain, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 November 2000 (26+ years old) and is registered under CIN U24233MP2000PTC014476.
Dallas Formulations reported revenue of ₹10.53 Cr for FY 2025 (up 47% YoY).
Dallas Formulations has 2 current directors:
- Mukesh Kumar - Whole-Time Director
- Rajesh Gupta - Director
Dallas Formulations reported a net profit of ₹17.31 Lakh (net margin 1.6%) and EBITDA of ₹85.56 Lakh (EBITDA margin 8.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dallas Formulations is 5% over three years and 2% over five years. In the latest year (FY 2025) revenue rose 47%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dallas Formulations is 02AACCD5000G1ZJ, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Dallas Formulations is U24233MP2000PTC014476. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dallas Formulations was incorporated on 24 November 2000, making it 26+ years old. It is registered with the Registrar of Companies, Gwalior.
Dallas Formulations can be reached through the website dallaspharma.com. Its registered office is in Ujjain, Madhya Pradesh, India.